PPMD Community

Blazena Kaderabkova's Discussions (32)

View

Discussions Replied To (28)	Replies	Latest Activity
"Hi Trinh, we were last week in our hospital in Motol Prague and there is expected th…" Blazena Kaderabkova replied Aug 26, 2013 to Ataluren - phase III	8	Sep 10, 2014 Reply by Trinh Nguyen
"Hi Michael, how long is your son on low dose ataluren? " Blazena Kaderabkova replied Feb 20, 2013 to Ataluren Webinar	45	Feb 17, 2014 Reply by Peter
"I was also surrprised with 31,3m. So the primary endpoint of the study was achieved…" Blazena Kaderabkova replied Jan 29, 2013 to Ataluren Webinar	45	Feb 17, 2014 Reply by Peter
"Yesterday were presented top line data from PTC. Ataluren in CF - success! http://pt…" Blazena Kaderabkova replied Jun 9, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme	51	Jun 12, 2012 Reply by Tamara Walters
"Dear Pat, There was said a lot of information, thank you very much. But I didnt unde…" Blazena Kaderabkova replied Jun 7, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme	51	Jun 12, 2012 Reply by Tamara Walters
"This news is also presented on www.distrofiamuscular.net/news.htm " Blazena Kaderabkova replied Jun 2, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme	51	Jun 12, 2012 Reply by Tamara Walters
"Hello, you need to go to the orthopaedist and use insoles, both at home and when you…" Blazena Kaderabkova replied May 9, 2012 to Walking change	29	May 14, 2012 Reply by wainaina muiruri
"I would like to ask you if any other studies of gentamicin will continue. Many thank…" Blazena Kaderabkova replied Mar 23, 2012 to Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons	5	Mar 28, 2012 Reply by Peter
"I only hope that it will affect the approval Ataluren. " Blazena Kaderabkova replied Feb 6, 2012 to One year on Phase 2 of GSX/Prosensa Trial	54	Feb 17, 2012 Reply by Ofelia Marin
"Hallo Amrit, thank you for this information I havent heard still about HT100. Its…" Blazena Kaderabkova replied Jan 5, 2012 to Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy	6	Jan 16, 2012 Reply by Debbie Bowman